EMEA-002196-PIP01-17

Key facts

Invented name
Active substance
Human Neutrophil Elastase Inhibitor (CHF6333)
Therapeutic area
Pneumology-allergology
Decision number
P/0367/2017
PIP number
EMEA-002196-PIP01-17
Pharmaceutical form(s)
  • Pressurised inhalation
  • suspension
Condition(s) / indication(s)
Treatment of bronchiectasis
Route(s) of administration
Inhalation use
Contact for public enquiries
Chiesi Farmaceutici S.p.A
Tel. +39 05212791
E-mail: info@chiesi.com
Decision type
RW: decision refers to a refusal on a request for waiver in all age groups for the listed condition(s)

Decision

How useful was this page?

Add your rating